Le Lézard
Classified in: Health
Subjects: PDT, PET

Arterra Launches First Veterinarian-Formulated Supplement to Help Dogs Live Longer, Happier and Healthier Lives


Adult and senior formulas designed to slow down the clock in healthy adult dogs and to turn back the clock in senior dogs

AUSTIN, Texas, Dec. 19, 2023 /PRNewswire/ -- Arterra, a cutting-edge dog supplement brand that is defining the new ceiling and standard for the industry to help dogs live happier, healthier, longer lives, announced its availability today. The veterinarian-formulated line includes adult and senior formulas designed to slow down the clock in healthy adult dogs and to turn back the clock in senior dogs already experiencing the signs of degenerative aging. The startup, which is VC-backed by industry veterans like Boulder Food Group and Gestalt Idea Group, is redefining pet supplement standards by prioritizing actual efficacy over label appeal. Eschewing the low-cost, low-benefit model of condition-specific formulas that have saturated the market, Arterra has developed a line of high-quality, research-backed products targeted for full body wellness and longevity.

"When I was in college in Los Angeles, I adopted a stray dog; he was emaciated, abused and desperate for a good home. I named him Arturo and he became my best friend," said Jonathan Willbanks, founder and CEO of Arterra. "As I noticed him starting to age, I began applying my knowledge of health and wellness to his daily life - first optimizing his diet, then one by one adding premium supplements to his regimen. He ended up living to be 16 1/2 and in nearly perfect health; 6 years older than the average lifespan for his breed. We've taken his formula and worked with leading integrative veterinarians to enhance it, bringing the high quality of care my best friend received to dog owners everywhere."

Arterra is an all-in-one formula designed to support your dog's entire body by supporting the underlying structural health and function of all key systems involved in degenerative aging, leading to a higher quality of life. Its 63 premium, science-backed ingredients support the whole body with joint health, cognition, mood, immune, allergy, gut and organ support in one daily, bacon-flavored scoop. Among its active ingredients are those that can be found in premium human supplements, such as Collagen, Bone Broth Protein, Lion's Mane Mushroom, Ashwagandha, Cordyceps Mushroom, Turmeric and many more.

Arterra's use of the 'entourage effect' sets it apart from its competitors. This means that the formula is built with various compounds and ingredients to be more effective and support each system through multiple directions rather than a single vector. For example, the current best-selling hip and joint supplement on the market contains just three active ingredients whereas the joint component of Arterra's formula alone contains 11 ingredients, all at significantly higher potency.

"Our mission with Arterra is to bring the care Arturo received to all dog owners, with none of the work and at a fraction of the cost," added Willbanks.

For more information about Arterra's product line or its origin story visit arterrapet.com.

About Arterra: Arterra is a cutting-edge dog supplement brand that is defining the new ceiling and standard for the industry to help dogs live happier, healthier, longer lives. By using 63 premium, vet-approved ingredients, this line is designed to slow down the clock in healthy adult dogs, and to turn back the clock in senior dogs already experiencing the symptoms of degenerative aging. With ingredients ranging from Collagen to Lion's Mane mushroom, Arterra targets different canine bodily systems to promote a healthy and prolonged life. For more information on Arterra visit arterrapet.com.

Media Contact: 
Maddison Cervantes
951.265.3009
[email protected] 

SOURCE Arterra


These press releases may also interest you

at 23:20
Full year 2023 revenue of $90.9 million compared to $99.4 million in 2022, and $90.5 million compared to $86.7 million on a normalized basis, excluding one-time COVID mandates.Q4 2023 gross profit margin1 of 39.7% was relatively flat compared to Q3...

at 23:07
On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and...

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...



News published on and distributed by: